1. Home
  2. ICUI vs NEOG Comparison

ICUI vs NEOG Comparison

Compare ICUI & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • NEOG
  • Stock Information
  • Founded
  • ICUI 1984
  • NEOG 1981
  • Country
  • ICUI United States
  • NEOG United States
  • Employees
  • ICUI N/A
  • NEOG N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • ICUI Health Care
  • NEOG Health Care
  • Exchange
  • ICUI Nasdaq
  • NEOG Nasdaq
  • Market Cap
  • ICUI 3.8B
  • NEOG 3.2B
  • IPO Year
  • ICUI 1992
  • NEOG 1989
  • Fundamental
  • Price
  • ICUI $160.82
  • NEOG $10.59
  • Analyst Decision
  • ICUI Buy
  • NEOG Buy
  • Analyst Count
  • ICUI 4
  • NEOG 2
  • Target Price
  • ICUI $199.67
  • NEOG $14.00
  • AVG Volume (30 Days)
  • ICUI 206.7K
  • NEOG 3.1M
  • Earning Date
  • ICUI 02-25-2025
  • NEOG 01-10-2025
  • Dividend Yield
  • ICUI N/A
  • NEOG N/A
  • EPS Growth
  • ICUI N/A
  • NEOG N/A
  • EPS
  • ICUI N/A
  • NEOG N/A
  • Revenue
  • ICUI $2,340,097,000.00
  • NEOG $913,828,000.00
  • Revenue This Year
  • ICUI $4.38
  • NEOG $0.37
  • Revenue Next Year
  • ICUI $0.34
  • NEOG $4.03
  • P/E Ratio
  • ICUI N/A
  • NEOG N/A
  • Revenue Growth
  • ICUI 4.04
  • NEOG N/A
  • 52 Week Low
  • ICUI $87.65
  • NEOG $10.61
  • 52 Week High
  • ICUI $196.26
  • NEOG $18.58
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 45.43
  • NEOG 31.77
  • Support Level
  • ICUI $155.00
  • NEOG $11.10
  • Resistance Level
  • ICUI $173.85
  • NEOG $11.96
  • Average True Range (ATR)
  • ICUI 5.70
  • NEOG 0.52
  • MACD
  • ICUI -0.86
  • NEOG -0.06
  • Stochastic Oscillator
  • ICUI 28.35
  • NEOG 2.01

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Share on Social Networks: